Swedencare (OM:SECARE) - Stock Price, News & Analysis

SECARE Stock Overview

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in Sweden, the United Kingdom, Rest of Europe, North America, Asia, and internationally. More details

SECARE fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	4/6
Past Performance	2/6
Financial Health	3/6
Dividends	0/6

Rewards

Trading at 67.6% below our estimate of its fair value

Earnings are forecast to grow 61.41% per year

Analysts in good agreement that stock price will rise by 26.8%

Risk Analysis

Profit margins (2.5%) are lower than last year (4%)

Swedencare AB (publ) Competitors

Camurus

OM:CAMX

SEK 33.7b

MedCap

OM:MCAP

SEK 8.3b

BioGaia

OM:BIOG B

SEK 10.7b

Biotage

OM:BIOT

SEK 12.4b

Price History & Performance

Summary of all time highs, changes and price drops for Swedencare
Historical stock prices
Current Share Price	SEK 46.28
52 Week High	SEK 69.12
52 Week Low	SEK 37.38
Beta	0.89
11 Month Change	-0.17%
3 Month Change	11.09%
1 Year Change	-19.99%
33 Year Change	-66.10%
5 Year Change	200.52%
Change since IPO	1,185.56%

Recent updates

Analysts Just Published A Bright New Outlook For Swedencare AB (publ)'s (STO:SECARE)

Feb 16

Do Swedencare's (STO:SECARE) Earnings Warrant Your Attention?

Dec 28

A Look At The Fair Value Of Swedencare AB (publ) (STO:SECARE)

Dec 06

Swedencare (STO:SECARE) Has A Rock Solid Balance Sheet

Oct 24

With EPS Growth And More, Swedencare (STO:SECARE) Is Interesting

Sep 12

Shareholder Returns

	SECARE	SE Pharmaceuticals	SE Market
7D	3.3%	0.9%	-0.2%
1Y	-20.0%	9.3%	11.8%

Return vs Industry: SECARE underperformed the Swedish Pharmaceuticals industry which returned 9.3% over the past year.

Return vs Market: SECARE underperformed the Swedish Market which returned 11.8% over the past year.

Price Volatility

Is SECARE's price volatile compared to industry and market?
SECARE volatility
SECARE Average Weekly Movement	4.4%
Pharmaceuticals Industry Average Movement	10.5%
Market Average Movement	5.5%
10% most volatile stocks in SE Market	11.2%
10% least volatile stocks in SE Market	3.3%

Stable Share Price: SECARE has not had significant price volatility in the past 3 months compared to the Swedish market.

Volatility Over Time: SECARE's weekly volatility (4%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1993	570	Hakan Lagerberg	www.swedencare.com

Swedencare AB (publ), together with its subsidiaries, develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in Sweden, the United Kingdom, Rest of Europe, North America, Asia, and internationally. The company offers animal nutritional supplements, treats, and grooming products under the Healthy Breeds name; pet supplements and topical products for various therapeutic areas, such as orthopedics, behavior, dermatology, odontostomatology, algology, gastroenterology, urology, nephrology, and ophthalmology under the Innovet name; and support and solutions for the veterinary community under the Stratford Animal Health name. It also provides pet health supplements under the NaturVet, VETCLASSICS, and NutriScience name; pet supplements, vitamins, dental care, ear cleaners, pilling agents, and topicals under the Pet MD name; and vet-formulated pet care products under the VetWELL name.

Swedencare AB (publ) Fundamentals Summary

How do Swedencare's earnings and revenue compare to its market cap?
SECARE fundamental statistics
Market cap	SEK 7.35b
Earnings (TTM)	SEK 62.10m
Revenue (TTM)	SEK 2.50b

118.4x

P/E Ratio

2.9x

P/S Ratio

Is SECARE overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SECARE income statement (TTM)
Revenue	SEK 2.50b
Cost of Revenue	SEK 1.06b
Gross Profit	SEK 1.45b
Other Expenses	SEK 1.39b
Earnings	SEK 62.10m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 13, 2025

Earnings per share (EPS)	0.39
Gross Margin	57.86%
Net Profit Margin	2.48%
Debt/Equity Ratio	18.0%

How did SECARE perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

59%

Payout Ratio

SECARE Stock Overview

Rewards

Risk Analysis

Swedencare AB (publ) Competitors

OM:CAMX

SEK 33.7b

OM:MCAP

SEK 8.3b

OM:BIOG B

SEK 10.7b

OM:BIOT

SEK 12.4b

Price History & Performance

Recent News & Updates

Consensus EPS estimates increase by 20%

Swedencare AB (publ) to Report Q4, 2024 Results on Mar 11, 2025

Swedencare AB (publ), Annual General Meeting, Apr 24, 2025

Consensus EPS estimates fall by 17%

Chief Executive Officer recently bought kr635k worth of stock

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Recent updates

Consensus EPS estimates increase by 20%

Swedencare AB (publ) to Report Q4, 2024 Results on Mar 11, 2025

Swedencare AB (publ), Annual General Meeting, Apr 24, 2025

Consensus EPS estimates fall by 17%

Chief Executive Officer recently bought kr635k worth of stock

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates fall by 15%

Price target decreased by 7.5% to kr61.50

Swedencare AB (publ) to Report Q2, 2025 Results on Jul 24, 2025

Chief Executive Officer recently bought kr874k worth of stock

Consensus EPS estimates fall by 22%

Chief Executive Officer recently bought kr941k worth of stock

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Swedencare AB (publ) to Report Q4, 2024 Results on Feb 13, 2025

Upcoming dividend of kr0.23 per share

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Swedencare AB (Publ) Announces Nomination Committee Appointments

Price target increased by 8.7% to kr50.00

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Swedencare AB (publ), Annual General Meeting, Apr 25, 2024

New minor risk - Share price stability

Price target decreased by 7.1% to kr46.00

Price target increased by 10% to kr49.50

Consensus EPS estimates fall by 31%, revenue upgraded

New minor risk - Profit margin trend

Second quarter 2023 earnings released: EPS: kr0.10 (vs kr0.49 in 2Q 2022)

Investor sentiment improves as stock rises 15%

Chief Executive Officer recently bought kr472k worth of stock

Symrise AG (XTRA:SY1) announces a mandatory public offer to acquire remaining 70% stake in Swedencare AB (publ) (OM:SECARE) for SEK 4.2 billion

Symrise AG (XTRA:SY1) announces a mandatory public offer to acquire remaining 70% stake in Swedencare AB (publ) (OM:SECARE) for SEK 4.2 billion

Investor sentiment improves as stock rises 15%

Less than half of directors are independent

Price target decreased by 12% to kr42.00

First quarter 2023 earnings: EPS misses analyst expectations

Does Swedencare (STO:SECARE) Deserve A Spot On Your Watchlist?

Investor sentiment improves as stock rises 22%

Upcoming dividend of kr0.22 per share at 0.8% yield

Chief Executive Officer recently bought kr241k worth of stock

Chief Executive Officer recently bought kr241k worth of stock

Consensus EPS estimates fall by 27%

Full year 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased by 14% to kr47.25

Swedencare AB (publ) to Report Fiscal Year 2022 Final Results on Apr 06, 2023

Swedencare AB (publ) to Report First Half, 2023 Results on Jul 27, 2023

Swedencare AB (publ) to Report Fiscal Year 2022 Results on Feb 16, 2023

Investor sentiment improved over the past week

Chief Executive Officer recently bought kr315k worth of stock

Chief Executive Officer recently bought kr328k worth of stock

Swedencare (STO:SECARE) Seems To Use Debt Quite Sensibly

Swedencare AB (publ), Annual General Meeting, Apr 28, 2023

Investor sentiment deteriorated over the past week

Here's Why We Think Swedencare (STO:SECARE) Might Deserve Your Attention Today

Price target decreased to kr75.00

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

With EPS Growth And More, Swedencare (STO:SECARE) Makes An Interesting Case